microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

BACKGROUND: One-third of cervical cancer patients are still diagnosed at advanced stages. The five-year survival rate is decreased in about 50% of advanced stage cervical cancer patients worldwide, and the clinical outcomes are remarkably varied and difficult to predict. One of the miRNAs known to b...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Park, Sunyoung, Kim, Jungho, Eom, Kiyoon, Oh, Sehee, Kim, Sunghyun, Kim, Geehyuk, Ahn, Sungwoo, Park, Kwang Hwa, Chung, Dawn, Lee, Hyeyoung
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501303/
https://ncbi.nlm.nih.gov/pubmed/31060525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5620-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items